-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOFRONTERA INC. ANNOUNCES FILING OF SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA (SBCC) WITH AMELUZ®-PDT

Reuters·12/02/2025 13:45:14

Please log in to view news